MedPath

A clinical trail to study the effect of Dashmoola taila Nasya and Shirodhara in headache

Not yet recruiting
Conditions
Diseases of the nervous system. Ayurveda Condition: Vatika Shiroroga ,
Registration Number
CTRI/2022/07/043928
Lead Sponsor
Uttarakhand Ayurved University
Brief Summary

*Charaka* has considered *Shirah* as the supreme important and major part of the body which is known as the *Uttamanga*. The *Vata pradhan Tridoshaj Nidan* causes the vitiation of *Vata* dominent *Tridosha* which enters in the *Shirah Pradesh* and manifest the symptoms of *Vatika Shiroroga*.Tension Headache is one such psycho somatic disease which can be compared with the *Vatika Shiroroga* described in *Ayurvedic* texts.

According to IHS ,globally, prevalence of Tension type Headache 42%. As quite a big number of people suffer from this disease, innumerable analgesics have been added to the arsenal of the modern physician, aftermath of which are that they are having serious side effect. Therefore, search for a safer management is of great importance.

The *Nasika* is said to be the gateway of the *Shirah* ,thus is the best route to eliminate the *Doshas* of the *Shirah*. Hence *Nasya* therapy is of primary importance in the treatment  of the *Shirorogas*. Also, *Shirodhara* is one of the allied *Panchakarma* procedures, which calm the mind and relaxes entire physiology. Beneficial action of *Shirodhara* in the management of *Vatika Shiroroga* has been reported. The efficacy of the "*Dashmoola Taila"* in all *Shiroroga* is well known as mentioned in the Bhaishajya *ratnawali.* Vata *Dosha* is responsible  for pain (*Shoola*).

So, to evaluate the  efficacy of *Dashmoola Taila Nasya* in *Vatika Shiroroga* (Tension Headache) and to evaluate the efficacy  of *Dashmoola Taila Shirodhara* in *Vatika Shiroroga* (Tension Headache) and to  compare the efficacy of *Dashmoola Taila Nasya* and *Dashmoola Taila Shirodhara* in *Vatika Shiroroga* trial is to conducted.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1.Patients having sign and symptoms of Vatika Shiroroga (Tension Headache) 2.Patient fit for Nasya 3.Patient fit for Shirodhara.

Exclusion Criteria
  • 1.Known case of Sinusitis 2.Any other types of infection associated with fever 3.Any pathology involving the eyes 4.Uncontrolled Hypertension 5.Diabetes mellitus 6.Migraine, Cluster headache, Trigeminal neuralgia 7.Known case of Seizures 8.Any other serious systemic illness 9.Secondary headache arising due to meningitis, tumor, cervical spondylosis etc.
  • 10.Nasya and Shirodhara ayogya patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
NO improvement: 0-25%0,7th, 14th,27th day
Mild improvement: 26-50%0,7th, 14th,27th day
Moderate improvement: 51-75%0,7th, 14th,27th day
Marked improvement: 76-100%0,7th, 14th,27th day
Secondary Outcome Measures
NameTimeMethod
Exacerbation in signs and symptoms27days

Trial Locations

Locations (1)

OPD & IPD in Rishikul campus

🇮🇳

Hardwar, UTTARANCHAL, India

OPD & IPD in Rishikul campus
🇮🇳Hardwar, UTTARANCHAL, India
Sakshi Sharma
Principal investigator
9813870455
sakshi0455@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.